Squamous Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Squamous Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of zimberelimab and domvanalimab for non-small cell lung cancer is currently active but no…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations [Phase 2]
A completed Phase 2 trial evaluating immunotherapy in combination with a second drug in patients with progressive advanced mucosal cancers a…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial for AK105 (anti-PD-1) in metastatic squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update for AZD4547 as second-line therapy in FGFR-positive recurrent stage IV squamous cell lung cancer (Phase 2/Phase 3) com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC [Phase 3]
Phase 3 study of SHR-1210 with carboplatin and paclitaxel in squamous non-small cell lung cancer is ongoing, with status not provided.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers [Phase 2]
Phase 2 clinical trial evaluating albumin-bound paclitaxel with gemcitabine in untreated stage IV or recurrent squamous cell lung cancer; re…
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers [Phase 1, Phase 2]
A phase 1/2 trial evaluating AZD2014 in combination with selumetinib in advanced cancers, including triple-negative breast cancer and squamo…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 [Phase 2]
Phase 2 trial investigating Necitumumab with gemcitabine as neoadjuvant therapy in surgically resectable squamous cell lung cancer; study te…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor [Phase 2]
Phase 2 trial evaluating single agent chemotherapy with or without nivolumab in advanced NSCLC patients with primary resistance to prior PD-…
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC [Phase 2]
Phase 2 clinical trial evaluating metronomic low-dose treosulfan, pioglitazone, and clarithromycin versus standard treatment in non-small ce…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating docetaxel with or without the FGFR inhibitor AZD4547 in recurrent non-small cell lung cancer, includin…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS research · 2014-11-11Clinical Trial Update: Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
The clinical trial update describes a trial comparing different surgical approaches for early-stage non-small cell lung cancer, including st…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Photodynamic Therapy in Treating Patients With Lung Cancer [Phase 1]
A Phase 1 trial update on photodynamic therapy for various lung cancer types, with the study status showing as completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Erlotinib for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding AE-941 to combination chemotherapy and radiation improves outcomes for patients with stage III non…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab [Phase 2]
This Phase 2 trial evaluated a regimen of radiation therapy with bevacizumab, paclitaxel, and carboplatin in patients with unresectable Stag…